INVESTMENT

• MedTech:

The fund invests in advanced medical devices and technologies, including but not limited to diagnostic imaging equipment, minimally invasive surgical tools, advanced diagnostic testing technologies, and therapeutic devices. By collaborating with clinical Key Opinion Leaders (KOLs), hospitals, and regulatory bodies, SaniMed assists startups with product technical validation, clinical trial design and implementation, regulatory pathways (such as FDA 510(k), De Novo, PMA), and market entry strategy development.

​

• BioTech:

Focusing on AI-driven drug discovery platforms, precision medicine applications (such as genomics and personalized treatments), the fund actively supports innovative enterprises that significantly accelerate drug discovery and therapeutic development timelines while enhancing treatment precision. It provides essential support in drug clinical validation, IP strategy planning and technology protection, as well as regulatory and clinical pathway management.

​

• TechBio​: 

The fund invests in biotechnology enterprises with high-tech integration, particularly those at the intersection of AI and biological sciences, such as synthetic biology, bio-manufacturing, and intelligent laboratory platforms. SaniMed helps startups create clear technology roadmaps, system architecture designs, and IP strategies to ensure sustained competitive advantages and market positions.​

​

• Digital Health:

Supporting digital platforms and solutions aimed at enhancing healthcare accessibility, patient engagement, and healthcare data insights, including telemedicine, remote monitoring, and patient management applications. The fund assists startups in defining clear product roadmaps, customer and market validation strategies, and compliance and data security strategies.

​

• Other AI-Related Healthcare Applications:

Focusing on innovative medical applications based on AI technology, such as real-time health monitoring, predictive analytics, and clinical decision support systems, SaniMed provides comprehensive support covering technology architecture planning, data management strategies, clinical and market validation, and commercialization pathways.​

​

Through detailed and strategic investment in these areas, the SaniMed Bridge Fund aims to drive innovation and practical application in healthcare technology, help startups achieve critical developmental milestones, and deliver efficient and robust investment returns for investors.